Legal Cannabis Market by Product Type, Distribution Channel, End User 2028

1
Global Legal Cannabis Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Legal Cannabis Market Research
Report The latest report by IMARC, titled
Legal Cannabis Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 finds that the global legal cannabis
market size reached US 20.7 Billion in 2022.
Legal cannabis is a drug obtained from Cannabis
Sativa, Indica, and Ruderalis plants. It has
psychoactive properties that help relieve chronic
pain, regulate and prevent diabetes, alleviate
anxiety, and treat depression and inflammatory
bowel diseases among individuals. It is also
used in the treatment of cancer, multiple
sclerosis, arthritis, glaucoma, epilepsy,
migraines, Alzheimers, Tourettes, Parkinson,
acquired immunodeficiency syndrome (AIDS),
amyotrophic lateral sclerosis (ALS), and
post-traumatic stress disorder (PTSD). Owing to
these properties, legal cannabis finds extensive
applications across the pharmaceutical industry
across the globe. Request Free Sample Report
https//www.imarcgroup.com/legal-cannabis-market/r
equestsample
4
Report Description and Highlights
Report Description

Global Legal Cannabis Market Trends The market
is primarily driven by the increasing number of
countries legalizing and decriminalizing
cannabis. In addition, oral cannabinoids are
effective antiemetics for adults suffering from
chemotherapy-induced nausea and vomiting. They
are also used to treat spasticity symptoms in
individuals with multiple sclerosis (MS)-related
spasticity. This, coupled with the expanding
pharmaceutical industry worldwide, is positively
influencing market growth. Besides this, the
market is also propelled by the rising approvals
legalizing the use of medications containing
cannabidiol (CBD) to treat rare epilepsy like
Lennox-Gastaut and Dravet syndrome, which are
difficult to control with other types of
medication. Moreover, the increasing awareness
among individuals regarding the medical benefits
of legal cannabis and the rising number of
research and clinical trials around the world are
also creating a positive market outlook. Looking
forward, IMARC Group expects the market value to
reach US 74.5 Billion by 2028, exhibiting a CAGR
of 23.9 during the forecast period
(2023-2028). Looking forward, the market value
is projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Source Mari
juana Hemp Breakup by Derivatives
Cannabidiol (CBD) Tetrahydrocannab
inol (THC) Breakup by Distribution Channel
Recreational Stores Pharmacies
Online Stores Others Breakup by E
nd User Medical Use Recreatio
nal Use Industrial Use

6
Report Description and Highlights
Report Description
Breakup by Region North America
Asia-Pacific Europe Latin A
merica
Middle East and Africa

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Aurora Cannabis Inc. Cannabis Sativa Inc. Canopy G
  rowth Corporation Green Thumb Industries GW Pharma
  ceuticals plc (Jazz Pharmaceuticals plc)
  HEXO Corp. Organigram Holdings Inc. Sundial Grower
  s Inc. The Cronos Group The Green Organic Dutchman
  Holdings Ltd. The Scotts Miracle-Gro Company Tilr
  ay VIVO Cannabis Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/legal-cannabis-market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us